The number of people getting treatment for pre-exposure prophylaxis (PrEP) against the human immunodeficiency virus (HIV) in France has been rising over the years. Among those who used such a treatment with Truvada or a generic equivalent between January 2016 and June 2021, 97.5 percent were men and 2.5 percent were women.
Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by gender
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
ANSM. (November 30, 2021). Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by gender [Graph]. In Statista. Retrieved December 31, 2024, from https://www.statista.com/statistics/1116567/hiv-aids-prep-users-france-gender/
ANSM. "Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by gender." Chart. November 30, 2021. Statista. Accessed December 31, 2024. https://www.statista.com/statistics/1116567/hiv-aids-prep-users-france-gender/
ANSM. (2021). Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by gender. Statista. Statista Inc.. Accessed: December 31, 2024. https://www.statista.com/statistics/1116567/hiv-aids-prep-users-france-gender/
ANSM. "Distribution of People Treated with Truvada® or Generic for Pre-exposure Prophilaxis (Prep) between January 2016 and June 2021, by Gender." Statista, Statista Inc., 30 Nov 2021, https://www.statista.com/statistics/1116567/hiv-aids-prep-users-france-gender/
ANSM, Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by gender Statista, https://www.statista.com/statistics/1116567/hiv-aids-prep-users-france-gender/ (last visited December 31, 2024)
Distribution of people treated with Truvada® or generic for pre-exposure prophilaxis (PrEP) between January 2016 and June 2021, by gender [Graph], ANSM, November 30, 2021. [Online]. Available: https://www.statista.com/statistics/1116567/hiv-aids-prep-users-france-gender/
